Immune Control

Madrigal Pharmaceuticals, Inc. is a biopharmaceutical company based in Conshohocken, PA, dedicated to developing innovative therapeutics for non-alcoholic steatohepatitis (NASH), also known as metabolic dysfunction associated steatohepatitis (MASH). Their primary focus lies in creating treatments for adults with NASH exhibiting moderate to advanced liver fibrosis, with ongoing research in Phase 3 trials for those with compensated cirrhosis. With the recent FDA accelerated approval of their first therapy, Madrigal Pharmaceuticals is at the forefront of pioneering treatments for NASH/MASH patients. The company's ambitious research endeavors have resulted in groundbreaking advancements, leading to the development of the first FDA-approved medication specifically tailored to address the challenges faced by patients with NASH. Generated from the website content

Neuromed Pharmaceuticals, located in Conshohocken, is a pharmaceutical company owned by Zalicus Inc. Specializing in pain therapies, the company develops, produces, markets, and sells drugs in Canada and the United States. Founded in 1998, Neuromed Pharmaceuticals offers a variety of medications to patients and provides ample parking at its office for convenience. Generated from their available business information

AmerisourceBergen Corporation, now known as Cencora, is a leading wholesale pharmaceutical company based in Conshohocken, PA. With over 100 years of combined experience, their subsidiary SmartSource Distribution offers a wide range of generic, branded, and over-the-counter pharmaceutical products, providing convenient access to affordable healthcare solutions for retail, small-chain, and long-term-care pharmacies. Backed by their market-leading expertise, SmartSource is committed to meeting the sourcing needs of their customers by offering extensive access to over 11,000 products, competitive prices, and efficient ordering options. As part of AmerisourceBergen, they ensure the highest quality care by shipping from VAWD accredited facilities and staying at the forefront of DSCSA implementation.Generated from the website